This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...
The popular image of Annaly Capital focuses on its hefty dividend. But the real investment story sits in the balance ...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...
Stablecoins aim to hold a steady value, but a stablecoin crash? can ripple through portfolios. Learn how pegs work, w...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
When a magnificent dividend stock drops 8%, it can feel painful. This guide shows how to separate price swings from l...
Fannie Mae updates its crypto mortgage framework with a 250% collateral requirement, reshaping how crypto assets can ...
After closing on a rental property, one diligence item can determine whether your cash flow meets expectations. This ...
When chip stocks tumble, investors face tough choices. This guide breaks down whether Nvidia, Broadcom, and Cerebras ...
Space-focused equities pulled back Monday after a week of sharp gains. Rocket Lab led losses, with SpaceMobile droppi...
A suspicious phone call claiming a court order pulled a Maryland woman into a tense sting. The scam fell apart throug...